
Technological innovations like AI are rapidly revolutionizing the medicine segment with improved drug discovery and development. AI is also contributing towards enhancing process efficiency and controlling drug discovery and development costs. These trends are creating promising tailwinds for the pharmaceutical industry.
Given the industry’s rosy prospects, it could be wise to invest in fundamentally strong medical stocks Pfizer Inc. (PFE), AstraZeneca PLC (AZN), and Novartis AG (NVS) for a profitable portfolio.